ZA200108220B - Novel synthesis and crystallization of piperazine ring-containing compounds. - Google Patents

Novel synthesis and crystallization of piperazine ring-containing compounds.

Info

Publication number
ZA200108220B
ZA200108220B ZA200108220A ZA200108220A ZA200108220B ZA 200108220 B ZA200108220 B ZA 200108220B ZA 200108220 A ZA200108220 A ZA 200108220A ZA 200108220 A ZA200108220 A ZA 200108220A ZA 200108220 B ZA200108220 B ZA 200108220B
Authority
ZA
South Africa
Prior art keywords
crystallization
containing compounds
piperazine ring
novel synthesis
synthesis
Prior art date
Application number
ZA200108220A
Other languages
English (en)
Inventor
Claude Singer
Anita Liberman
Nina Finkelstein
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of ZA200108220B publication Critical patent/ZA200108220B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200108220A 1999-04-19 2001-10-05 Novel synthesis and crystallization of piperazine ring-containing compounds. ZA200108220B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13004799P 1999-04-19 1999-04-19

Publications (1)

Publication Number Publication Date
ZA200108220B true ZA200108220B (en) 2006-02-26

Family

ID=22442814

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200108220A ZA200108220B (en) 1999-04-19 2001-10-05 Novel synthesis and crystallization of piperazine ring-containing compounds.

Country Status (16)

Country Link
JP (1) JP2004500324A (enExample)
KR (1) KR20020019902A (enExample)
CN (4) CN1679586A (enExample)
CA (1) CA2368815A1 (enExample)
CZ (1) CZ20013658A3 (enExample)
HK (1) HK1044116A1 (enExample)
HR (1) HRP20010747A2 (enExample)
HU (1) HUP0200839A3 (enExample)
IL (1) IL146023A0 (enExample)
PL (1) PL366289A1 (enExample)
RU (1) RU2001128229A (enExample)
SK (1) SK14672001A3 (enExample)
TR (1) TR200103028T2 (enExample)
WO (1) WO2000062782A1 (enExample)
YU (1) YU74101A (enExample)
ZA (1) ZA200108220B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001038329A1 (en) * 1999-11-24 2001-05-31 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine crystals and process for producing the same
WO2001042239A1 (en) * 1999-12-13 2001-06-14 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
US6660730B2 (en) * 2000-11-27 2003-12-09 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine and process for preparing the same
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
ES2246161B1 (es) * 2004-07-22 2007-04-01 Medichem, S.A. Proceso mejorado para la fabricacion de mirtazapina.
JP4848704B2 (ja) * 2004-08-24 2011-12-28 住友化学株式会社 ２−（４−メチル−２−フェニルピペラジン−１−イル）−３−シアノピリジンの製造方法
JP5192707B2 (ja) 2007-03-22 2013-05-08 住友化学株式会社 ミルタザピンの製造方法
US7994314B2 (en) 2007-04-11 2011-08-09 N.V. Organon Method for the preparation of an enantiomerically pure benzazepine
WO2008125578A2 (en) 2007-04-11 2008-10-23 N.V. Organon A method for the preparation of mirtazapine
KR101485418B1 (ko) 2013-05-29 2015-01-26 주식회사 메디켐코리아 고순도 미르타자핀의 제조방법
JP2017088564A (ja) * 2015-11-13 2017-05-25 株式会社トクヤマ ミルタザピンの製造方法
JP6571497B2 (ja) * 2015-11-13 2019-09-04 株式会社トクヤマ ミルタザピンの製造方法
CN108191873B (zh) * 2018-01-08 2021-09-24 山东省食品药品检验研究院 一种盐酸米安色林的纯化方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.

Also Published As

Publication number Publication date
CZ20013658A3 (cs) 2002-08-14
CN1680374A (zh) 2005-10-12
HRP20010747A2 (en) 2002-12-31
CA2368815A1 (en) 2000-10-26
CN1679586A (zh) 2005-10-12
WO2000062782A1 (en) 2000-10-26
HUP0200839A3 (en) 2003-05-28
JP2004500324A (ja) 2004-01-08
HUP0200839A2 (en) 2002-08-28
SK14672001A3 (sk) 2002-11-06
RU2001128229A (ru) 2003-07-10
PL366289A1 (en) 2005-01-24
IL146023A0 (en) 2002-07-25
YU74101A (sh) 2004-09-03
CN1356903A (zh) 2002-07-03
TR200103028T2 (tr) 2002-01-21
CN1680365A (zh) 2005-10-12
KR20020019902A (ko) 2002-03-13
HK1044116A1 (zh) 2002-10-11

Similar Documents

Publication Publication Date Title
IL148964A0 (en) Piperazine compounds
EP1140083A4 (en) NEW CONNECTIONS
ZA200108220B (en) Novel synthesis and crystallization of piperazine ring-containing compounds.
HUP0202255A3 (en) Crystalline 1-methylcarbapenem compounds and pharmaceutical compositions containing them
GB9902084D0 (en) Novel compounds
AU2001269685A1 (en) Crystallization of 4-diphosphocytidyl-2-c-methylerythritol synthesis
GB9909756D0 (en) Synthesis of polycarbonates
AU5587200A (en) Synthesis of substituted amidines
IL146024A0 (en) Novel synthesis of piperazine ring
EP1178805A4 (en) NOVEL SYNTHESIS AND CRYSTALLIZATION OF PIPERAZINE-CONTAINING COMPOUNDS
MXPA01009617A (es) Sisntesis de propanoatos de 3-amino-3-arilo.
AU1611900A (en) Process for the synthesis of quinazolinones
GB0011407D0 (en) Synthesis of substituted prolines
GB9901256D0 (en) Novel compounds
IL137918A0 (en) Solid support synthesis of 2-oxopiperazines
AU4015900A (en) Synthesis of epoxy-thf compounds
ZA993477B (en) Polymorphs of a crystalline pyrazine-monohydrochloride and their pharmaceutical compositions.
GB9921408D0 (en) Rapid synthesis of manganite compounds
GB9902070D0 (en) Novel compounds
PL337598A1 (en) Novel compound - derivative of (r)-3-hydroxynonanal
PL336261A1 (en) Dissymmetrical synthesis of benzoxazinones through novel intermediate compounds
GB9828176D0 (en) Synthesis of epibatidine derivatives
GB9917115D0 (en) ›-lactone synthesis
GB9902009D0 (en) Novel compounds
GB9902069D0 (en) Novel compounds